UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Acarizax (12 ...

VMPL New Delhi [India] January 31 Allergic rhinitis is a very common condition often termed as hay fever which affects millions of people globally This chronic condition arises from the reaction of th ...

The treatment, known as 12 SQ-HDM SLIT, will help with the allergy which can be debilitating and cause facial swelling, ...

Rhinitis and pharmacological agents used for treatment are considered factors that could alter the rate and extent of absorption of drugs administered by the nasal route. The purpose of this study ...

New NHS treatment gives hope to thousands who suffer from common allergy - The first-of-its-kind tablet will offer relief ...

The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...

ALLERGIC rhinitis (AR) is a prevalent upper airway condition caused by an IgE-mediated type 1 hypersensitivity reaction to ...

NICE has endorsed a new daily tablet treatment, Acarizax, designed to alleviate symptoms and enhance the quality of life for ...

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of ACARIZAX® for the treatment of persistent, moderate to ...

A new treatment for severe dust mite allergy has been recommended by NICE, for patients whose symptoms have not been helped ...

Conventional treatments for allergic rhinitis may also improve asthma outcomes in patients with both conditions. Read now!

Thousands of people with a severe dust mite allergy could benefit from a "life changing" new daily treatment. The National ...